ProShares UltraPro NASDAQ Biotechnology (NASDAQ:UBIO)’s share price were down 4.8% during mid-day trading on Friday . The company traded as low as $23.06 and last traded at $23.06, approximately 2,480 shares changed hands during trading. A decline of 95% from the average daily volume of 47,439 shares. The stock had previously closed at $24.23.

The company has a 50 day moving average of $23.74.

A hedge fund recently bought a new stake in ProShares UltraPro NASDAQ Biotechnology stock. Exencial Wealth Advisors LLC purchased a new stake in shares of ProShares UltraPro NASDAQ Biotechnology (NASDAQ:UBIO) during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 7,125 shares of the company’s stock, valued at approximately $209,000. Exencial Wealth Advisors LLC owned approximately 0.62% of ProShares UltraPro NASDAQ Biotechnology at the end of the most recent quarter.

Featured Article: Is a Roth IRA right for you?

Receive News & Ratings for ProShares UltraPro NASDAQ Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares UltraPro NASDAQ Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.